Fort Washington Investment Advisors 13F: New $16M Stake in OMCL

Fort Washington Investment Advisors has taken a new position in Omnicell, Inc. (NasdaqGS: OMCL), acquiring 458,751 shares valued at about $15.6 million. This move was disclosed in a filing on October 15, 2026.

What Changed in Fort Washington Investment Advisors' Omnicell Position

Fort Washington's new position reflects an entry into Omnicell with 458,751 shares, marking its first stake in the company. As the firm did not hold any previous shares, this represents a fresh investment.

Other Institutional Activity in Omnicell

Several other institutional investors have reported their positions in Omnicell. Blackrock Inc. increased its stake by 332,259 shares, bringing its total to 7,539,602 shares, valued at approximately $266.8 million. State Street Corporation also raised its holdings by 135,173 shares, ending with 2,085,723 shares worth around $73.8 million. Both Vanguard Portfolio Management and Wellington Management Group slightly adjusted their positions, with Vanguard decreasing its stake by 63,329 shares and Wellington paring back by 6,497 shares.

Omnicell, Inc. Stock Down 2.0%

As of October 16, 2026, Omnicell shares are trading at $35.22, which is above the 52-week low of $29.09 but significantly below the moving averages — around 1.7% above the 50-day average and 11.3% below the 200-day average. This position might attract attention given its current valuation relative to the analysts' target mean price of $57.86.

Recent Earnings

Omnicell generated approximately $1.25 billion in revenue over the trailing twelve months, reflecting a year-over-year revenue growth of 7.5%. The company reported an EPS of $0.84 and a net margin of 3.1%. The next earnings report is scheduled for October 29, 2026.

Insider Buying and Selling at Omnicell, Inc.

Recent insider transactions have shown some activity. Corey J. Manley, an officer, sold 5,025 shares at an average price of $43.22 on May 18, 2026, totaling about $217,180. Additionally, Nnamdi Njoku, the Chief Operating Officer, sold 3,090 shares on the same day, valued at approximately $133,550. CEO Randall A. Lipps sold 10,000 shares at $47.00 on July 15, 2026, worth $470,000.

Analysts Set New Price Targets

On July 31, 2026, Wells Fargo maintained an Overweight rating with a price target of $50, while Keybanc also maintained an Overweight rating but adjusted its target to $65. Piper Sandler reiterated an Overweight rating with a target of $45. The consensus from analysts suggests a strong buy recommendation, with a mean target price of $57.86.

About Omnicell, Inc.

Omnicell, Inc. provides healthcare technology solutions, specializing in medication management and automated dispensing systems. The company serves hospitals and health systems, aiming to improve efficiency in patient care. This new stake by Fort Washington could indicate growing confidence in Omnicell's future performance amid its ongoing technological advancements.

Bottom Line

Fort Washington Investment Advisors' new investment in Omnicell may provide insights into its outlook for the healthcare technology market. As the company prepares for its next earnings report on October 29, 2026, investors will be keen to see how its performance aligns with market expectations. Note that this filing reflects the portfolio position as of the reporting date and may not represent current holdings.